Drug Screening and Discovery

Drug Screening and Discovery is the process of identifying potential compounds for therapeutic use. Through high-throughput screening techniques, researchers assess thousands of compounds for biological activity against specific targets, such as proteins or enzymes involved in disease pathways. Successful candidates undergo further testing to evaluate safety, efficacy, and pharmacokinetic properties. This iterative process leads to the development of new medications, addressing unmet medical needs and improving patient care. Drug screening and discovery play a crucial role in advancing medicine and treating complex diseases.

    Related Conference of Drug Screening and Discovery

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Drug Screening and Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in